BIMB On Other Exchanges
Symbol
Exchange
Mumbai

bharat immunologicals & bio (BIMB) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for BHARAT IMMUNOLOGICALS & BIO (BIMB)
\

Related News

No related news articles were found.

bharat immunologicals & bio (BIMB) Related Businessweek News

No Related Businessweek News Found

bharat immunologicals & bio (BIMB) Details

Bharat Immunologicals & Biologicals Corporation Limited, a biotechnology company, manufactures and markets a range of pharmaceuticals products in India. It offers oral polio vaccines, zinc tablets, diarrhea management kits, ready to use therapeutic food, low calorie sweetener tablets, etc. The company was founded in 1989 and is based in Bulandshahr, India.

Founded in 1989

bharat immunologicals & bio (BIMB) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

bharat immunologicals & bio
Bharat Immunologicals & Biologicals Corporation Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2019

Bharat Immunologicals & Biologicals Corporation Limited announced earnings results for the fourth quarter ended March 31, 2019. For the fourth quarter, the company announced total revenue was INR 726.971 million compared to INR 223.048 million a year ago. Net loss was INR 22.421 million compared to INR 13.060 million a year ago. Basic loss per share was INR 0.52 compared to INR 0.3 a year ago. For the full year, total revenue was INR 862.835 million compared to INR 361.925 million a year ago. Net loss was INR 55.568 million compared to INR 42.620 million a year ago. Basic loss per share was INR 1.29 compared to INR 0.99 a year ago.

Bharat Immunologicals & Biologicals Corporation Limited to Report Q1, 2019 Results on Apr 11, 2019

Bharat Immunologicals & Biologicals Corporation Limited announced that they will report Q1, 2019 results on Apr 11, 2019

Bharat Immunologicals & Biologicals Corporation Limited, Board Meeting, Apr 11, 2019

Bharat Immunologicals & Biologicals Corporation Limited, Board Meeting, Apr 11, 2019. Agenda: To approve and take on record the un-audited quarterly financial results of the company for the quarter ended March 31, 2019.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

BIMB Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for BIMB.
View Industry Companies
 

Industry Analysis

BIMB

Industry Average

Valuation BIMB Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book -- Not Meaningful
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BHARAT IMMUNOLOGICALS & BIO, please visit bibcol.in. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.